Delivery Order SPE2DB24D6041-SPE2DB25FKBWK

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,585.35, is for the delivery of 4,567,152,370 units of Erythromycin 250 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,254.80, is for the delivery of Erythromycin 250 mg tablets to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This...
This federal contract award, valued at $1,183.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560956009 - Erythromycin 250 mg tablets in 30-count packages. This award is a Firm Fixed Price Delivery Order with a completion date of May 17, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,831.11 firm fixed-price delivery order is for the supply of 4,568,184,534 units of Erythromycin 250 mg tablets. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA...
This federal contract award is for the delivery of Erythromycin 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,933.82 and a period of performance through March 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $8,222.53, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,235,609 units of the pharmaceutical product Erythromycin 250 mg Tablet in 100-count packages. The contract has a period of performance extending through May 14, 2025 and is a firm fixed-price, non-set-aside award....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,539 Erythromycin 500 mg tablets. The fixed-price delivery order, valued at $2,994.60, has an ultimate completion date of October 20, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,124.46 firm fixed-price delivery order is for the supply of 4,567,015,776 units of the drug Erythromycin 250 mg tablets. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. The award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $25,199.43 firm fixed-price delivery order is for the supply of 4,565,511,300 units of 250mg Erythromycin tablets. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, as the prime contractor. The award is for the delivery of Erythromycin 250 mg tablets, with a potential value of $4,159.09 and a completion date of February 2, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a larger...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBWK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.90, is a delivery order for the procurement of 4567711737 Erythromycin 250 mg tablets.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is for a firm fixed-price delivery order with a completion date of March 28, 2025.

Generated 6/26/25, 10:18 AM